1-151760844-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031420.4(MRPL9):c.644G>A(p.Arg215Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000145 in 1,588,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R215W) has been classified as Uncertain significance.
Frequency
Consequence
NM_031420.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL9 | NM_031420.4 | c.644G>A | p.Arg215Gln | missense_variant | Exon 6 of 7 | ENST00000368830.8 | NP_113608.1 | |
MRPL9 | NM_001300733.2 | c.542G>A | p.Arg181Gln | missense_variant | Exon 5 of 6 | NP_001287662.1 | ||
MRPL9 | NR_125331.2 | n.701G>A | non_coding_transcript_exon_variant | Exon 6 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000209 AC: 3AN: 143690Hom.: 0 Cov.: 27
GnomAD3 exomes AF: 0.0000251 AC: 6AN: 239036Hom.: 0 AF XY: 0.0000385 AC XY: 5AN XY: 129720
GnomAD4 exome AF: 0.0000138 AC: 20AN: 1445044Hom.: 0 Cov.: 30 AF XY: 0.0000195 AC XY: 14AN XY: 719168
GnomAD4 genome AF: 0.0000209 AC: 3AN: 143690Hom.: 0 Cov.: 27 AF XY: 0.0000433 AC XY: 3AN XY: 69336
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.644G>A (p.R215Q) alteration is located in exon 6 (coding exon 6) of the MRPL9 gene. This alteration results from a G to A substitution at nucleotide position 644, causing the arginine (R) at amino acid position 215 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at